Genetics of ALS progression

Jun 01, 2008

An upcoming paper in the June 1 issue of G&D, from Drs. Hidenori Ichijo and Hideki Nishitoh (University of Tokyo) and colleagues, lends new and valuable insight into the genetics of ALS.

Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, is a rapidly progressive, fatal neurological disease involving the degeneration and death of motor neuron cells.

ALS is one of the most common neuromuscular diseases worldwide, affecting as roughly 25,000 Americans, with an estimated 5,000 new diagnoses each year. The life expectancy of ALS patients is usually 3 to 5 years after diagnosis.

5-10 percent of all ALS cases are inherited. About 20% of these familial ALS cases are the result of an inherited genetic mutation on chromosome 21, in the gene encoding for the superoxide dismutase 1 (SOD1) enzyme. SOD1 is an antioxidant that protects the body from DNA damage caused by the accumulation of free radicals within cells. However, several reports have demonstrated that mutated SOD1 toxicity is not due to decreased antioxidant activity, but rather to a ‘gain of unknown toxic function’.

In their upcoming paper, Dr. Ichijo and colleagues delineate how mutations in SOD1 lead to motor neuron cell death and the progression of ALS. The researchers characterized a molecular pathway by which mutated SOD1 contributes to the accumulation of malformed proteins inside the endoplasmic reticulum (ER) compartment of motor neuron cells. Beyond a certain threshold, this ER stress induces cell death.

Interestingly, Dr. Ichijo’s team found that the inactivation of certain key factors in this pathway could mitigate neurodegeneration and prolong survival in a mouse model of inherited ALS.

Although not all familial ALS cases are due to the SOD1 mutation (and not all persons with a mutated form of SOD1 develop ALS), further insight into mechanism of the disease will undoubtedly aid in the development of an effective treatment for ALS.

Source: Cold Spring Harbor Laboratory

Explore further: US cautiously optimistic after no new Ebola in 5 days

add to favorites email to friend print save as pdf

Related Stories

The role of metal ions in amyotrophic lateral sclerosis

Mar 10, 2011

(PhysOrg.com) -- Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, is a progressive neurodegenerative disease that affects motor neurons in the spinal cord, leading to muscle weakness, ...

Mysterious cells may play role in ALS

Nov 17, 2010

(PhysOrg.com) -- By tracking the fate of a group of immature cells that persist in the adult brain and spinal cord, Johns Hopkins researchers discovered in mice that these cells undergo dramatic changes in ALS, also known ...

Researchers identify protein associated with sporadic ALS

Oct 18, 2010

Researchers at the University of Massachusetts Medical School have uncovered new evidence suggesting that the SOD1 gene, which is implicated in 20 percent of inherited cases of amyotrophic lateral sclerosis (ALS, or Lou Gehrig's ...

Recommended for you

US cautiously optimistic after no new Ebola in 5 days

1 hour ago

With no new Ebola cases in five days, US authorities were cautious but hopeful Monday that the virus has been contained in the United States after a flawed response revealed shortcomings in the system.

Nigeria declared Ebola-free in 'spectacular success'

1 hour ago

Nigeria was declared Ebola-free on Monday in a "spectacular success" in the battle to contain the spread of a virus which is devastating Guinea, Sierra Leone and Liberia where more than 4,500 people have died.

EU says 'increased' effort needed to tackle Ebola

2 hours ago

European Union foreign ministers agreed Monday to step up efforts to contain Ebola to prevent it becoming a global threat, including ensuring proper care for international health workers.

User comments : 0